Status:
RECRUITING
Efficacy and Safety of tACS for Depression: a Multicenter RCT Study
Lead Sponsor:
Ruijin Hospital
Collaborating Sponsors:
Shanghai Mental Health Center
Shandong Mental Health Center
Conditions:
Depression Disorders
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Transcranial alternating current stimulation (tACS) is a promising non-invasive technique for major depression, because of its advantage of lower risks and expenses compared to other therapies such as...
Eligibility Criteria
Inclusion
- Clinical diagnosis of depressive disorder;
- Age ranges between 18 and 65 years;
- HDRS-17 score equals to or above 8;
- No medical history/Under stable antidepressant treatment in one month;
Exclusion
- Combination of other psychotic disorders and neurological diseases;
- History of invasive brain surgeries;
- Non-invasive neurostimulation treatments within 3 months;
- Physical condition that may endanger patients' safety during the study.
Key Trial Info
Start Date :
October 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 8 2026
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06891326
Start Date
October 8 2024
End Date
October 8 2026
Last Update
March 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine
Shanghai, China, 200025
2
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China, 200025